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Edited by Jesus AvilaAbstract Proteolytic post-translational modiﬁcation has been
proposed as an early stage event in the aggregation of s protein
and formation of neuroﬁbrillary lesions in Alzheimers disease.
Caspases and other proteases cleave s in vivo at discrete loca-
tions including Asp421 and Glu391. Both cleavage products are
prone to aggregation relative to wild-type, full-length s protein.
To determine the mechanism underlying this eﬀect, the ﬁbrilliza-
tion of s truncated after Asp421 and Glu391 residues was charac-
terized in a full-length four-repeat s background using
quantitative electron microscopy methods under homogeneous
nucleation conditions. Both C-terminal truncations decreased
critical concentration relative to full-length s, resulting in more
ﬁlament mass at reaction plateau. Moreover, truncation directly
augmented the eﬃciency of the nucleation reaction. The results
suggest the mechanism through which C-terminal proteolysis
can modulate s ﬁlament accumulation depending on whether it
precedes or follows nucleation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Alzheimers disease1. Introduction
Proteolytic post-translational modiﬁcation of various pro-
teins contributes to the pathogenesis of Alzheimers disease
(AD) [1], Huntingtons disease [2], and gelsolin amyloidosis,
Finnish type [3] by driving formation of fragments with in-
creased amyloidogenic potential relative to their full-length
precursor forms. Proteolytic modiﬁcation also has been impli-
cated in the formation of toxic and aggregation-prone frag-
ments of s protein, a microtubule-associated protein that
aggregates into ﬁlaments within the characteristic neuritic le-
sions of frontotemporal dementias as well as AD [4]. s trunca-
tions can be detected at early stages of AD cognitive decline [5]
and their accumulation in AD hippocampus correlates inver-
sely with cognition [6]. s sequences C-terminal to the microtu-
bule-binding region are particularly sensitive to proteolysis,
and are substrates for cathepsins [7], caspases [6,8–11], andAbbreviations: AD, Alzheimers disease; TEM, transmission electron
microscopy
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the residue numbering of full-length wild-type four repeat s
isoform hs40; [12]) can be detected in mild cognitive impair-
ment and AD but not in non-demented control brains [6,8].
As neuritic pathology progresses, C-terminal truncations ex-
tend beyond Asp421 to at least as far as Glu391, which lies adja-
cent to the C-terminal limit of the protease-resistent core of
brain-derived paired-helical ﬁlaments [13,14]. Relative to full-
length hs40, puriﬁed recombinant s proteins truncated after
Glu391 or Asp421 (i.e., hs40D392 and hs40D422) are prone to
aggregation in vitro, yielding faster rates of ﬁbrillization and
more ﬁlament mass at reaction plateau [5,6]. C-terminally
truncated s also has been suggested to ‘‘seed’’ aggregation
reactions through secondary nucleation, where pre-formed ﬁl-
aments composed of truncated s serve as the nidus for addition
of full-length smolecules [6,15]. Nonetheless, neither the mech-
anism through which these eﬀects occur nor its signiﬁcance for
lesion formation are known.
Clarifying how C-terminal truncation modulates s aggrega-
tion has been diﬃcult in part because full-length s protein
ﬁbrillizes poorly in vitro in the absence of exogenous inducers
[16]. These agents, which include anionic surfactant micelles
and anionic microspheres, promote heterogeneous nucleation
(i.e., nucleation owing to the presence of foreign particles) on
their surfaces from which s ﬁlaments then extend in an elonga-
tion reaction [17–19]. Heterogeneous nucleation may mediate
the aggregation-inducing activity of other polyanionic macro-
molecular inducers as well, such as glycosaminoglycans
[20,21]. Because the rate of heterogeneous nucleation depends
on the concentration of nucleating particles (or their surface
area) in addition to protein supersaturation [22], the eﬀects
of post-translational modiﬁcations on s aggregation have been
diﬃcult to interpret mechanistically. Moreover, the use of sta-
tic light scattering methods uncorrected for the presence of in-
ducer to assess the eﬀect of s C-terminal truncation on reaction
rates [5,6] has complicated interpretation of reaction progress
data [23].
Here we examine the eﬀect of C-terminal truncation in the
presence of thiazin red, a small-molecule ﬁbrillization inducer
of full-length s isoforms. Small-molecule dyes appear to drive
aggregation reactions by stabilizing assembly-competent pro-
tein conformations [17,24]. Once these conformations are
adopted, aggregation proceeds spontaneously much like reac-
tions mediated by homogeneous nucleation. Furthermore,
the resultant amyloidgenic conformations support ﬁbrillization
at submicromolar s concentrations, well within levels thought
to be physiological in vivo [17,18]. Under these conditions, it is
possible to detect and quantify the eﬀect of post-translationalblished by Elsevier B.V. All rights reserved.
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the ﬁbrillization reaction. The results indicate that C-terminal
truncation accelerates s ﬁbrillization principally by lowering
critical concentration but also by directly accelerating the
nucleation reaction.2. Materials and methods
2.1. Materials
Recombinant His-tagged wild-type hs40 and C-terminal truncation
mutants hs40D392 and hs40D422 were prepared as described previously
[5,25]. Stock solutions of ﬁbrillization inducer thiazin red were pre-
pared as described [17].
2.2. s aggregation assay
s preparations were incubated without agitation in assembly buﬀer
(10 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM dithiothreitol) at room
temperature for up to 24 h in the presence or absence of 100 lM thia-
zin red inducer. For transmission electron microscopy (TEM) analysis,
aliquots were removed, treated with 2% glutaraldehyde (ﬁnal concen-
tration), mounted on formvar/carbon-coated 300 mesh grids, and neg-
atively stained with 2% uranyl acetate as described previously [19,26].
The lengths of all ﬁlaments were estimated using ImageJ software
(National Institutes of Health, Bethesda, MD) without a length cutoﬀ
ﬁlter.
2.3. Analytical methods
Sigmoidal reaction progress curves were ﬁt to the Gompertz func-
tion [23]:
y ¼ aee
ðtti Þ
b
 
; ð1Þ
where y is total ﬁlament length measured by TEM at time t, ti is the
inﬂection point corresponding to the time of maximum growth rate,
a is the maximum total ﬁlament length at plateau, and b = 1/kapp,
where kapp is the apparent ﬁrst order rate constant describing growth
of the ﬁlament population in units of time1. Lag times, deﬁned as
the time where the tangent to the point of maximum polymerization
rate intersects the abscissa of the sigmoidal curve [27], were calculated
as ti  b [23].
Critical concentrations were determined by incubating s samples
(0.2–1.0 lM, bulk concentrations) for 24 h in assembly buﬀer at room
temperature in the presence of 100 lM thiazin red without agitation.
Samples were analyzed by TEM as described above, and critical con-
centrations were estimated from the abscissa intercepts of concentra-
tion response curves after least squares linear regression. All
statistical parameters estimated from linear (e.g., critical concentra-
tion) or non-linear (e.g., lag time) regression analyses are presented
as ±S.E. of the estimate.Fig. 1. C-terminal truncation modulates s ﬁbrillization. Fibrillization
of hs40 and C-terminal truncation mutants hs40D422 and hs40D392 (all
at 600 nM bulk concentration) was viewed by TEM after 24 h
incubation at 20 C in the presence of thiazin red inducer (100 lM).
C-terminal truncation resulted in increased numbers and total length
of ﬁlaments.3. Results
3.1. C-terminal truncation modulates critical concentration
C-terminal truncation yields more ﬁlament mass than wild-
type hs40 when incubated in the presence of anionic inducer
under reducing conditions [5,6]. To determine whether this ef-
fect could be reproduced in the presence of thiazin red inducer,
equal bulk concentrations of wild-type hs40 and truncation
mutants hs40D392 and hs40D422 were incubated at room tem-
perature in the presence of 100 lM thiazin red for 24 h and
examined by TEM. These two mutants were selected for study
because each represents a histochemically conﬁrmed cleavage
event, with hs40D422 corresponding to caspase-mediated prote-
olysis detectable in early stage AD and hs40D392 corresponding
to near maximal C-terminal cleavage [8,13]. All preparations
ﬁbrillized with twisted morphology as described previously[17], with no morphological diﬀerences apparent among sam-
ples (Fig. 1). However, both hs40D392 and hs40D422 truncation
mutants yielded more and longer ﬁlaments compared to wild-
type hs40 (Fig. 1). These data indicate that the aggregation
promoting eﬀects of C-terminal truncation are inherent in
the preparations and not dependent on members of the poly-
anionic family of inducers such as glycosaminoglycans [6] or
anionic-surfactant micelles [5].
The amount of s ﬁlament mass attained after the prolonged
incubation described above corresponds to the plateau phase
of s ﬁbrillization when the rate of protein addition to ﬁlament
ends equals the rate of protomer dissociation (evidence for pla-
teau phase is shown in Section 3.2 below). That equilibrium is
characterized by a ‘‘critical’’ concentration corresponding to
the maximum solubility of protein above which all additional
assembly-competent protein enters the polymeric phase [28]. It
is the highest concentration of protein incapable of supporting
ﬁbrillization, and therefore can be estimated from the depen-
dence of ﬁbrillization on bulk protein concentration [29]. To
determine whether C-terminal truncation modulated this equi-
librium, the critical concentration of hs40D392 and hs40D422
were estimated after 24 h incubation at room temperature
using TEM and compared to values for wild-type hs40. The
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was 207 ± 9 nM (Fig. 2; Table 1). In contrast, critical concen-
trations progressively decreased with truncation to values as
low as 60 ± 29 nM (Table 1). These data suggest that the in-
creased ﬁbrillization at reaction plateau produced by C-termi-
nal truncation resulted from higher aﬃnity between ﬁlament
ends and assembly-competent s.
3.2. C-terminal truncations modulate nucleation rates
Small molecule dyes such as thiazin red appear to induce pro-
tein aggregation with near homogeneous nucleation kinetics be-
cause they act to stabilize partially folded, aggregation-prone
conformations in solution [17,24]. Under these conditions, the
degree of protein supersaturation provides the principal driving
force for nucleation [30]. As a result, the rate of homogeneous
nucleation is directly dependent on the degree of supersatura-
tion [31]:
dF =dt ¼ KnðA KcritÞn; ð2Þ
where dF/dt is the rate of formation of ﬁlament nuclei,
A  Kcrit is the concentration of monomer above the critical
concentration (i.e., the degree of supersaturation), n represents
the nucleus cluster size, and Kn is an operational quantity rep-
resenting the homogeneous nucleation rate constant with units
that depend on the size of n. Therefore, post-translational
modiﬁcations that lower the critical concentration, increaseFig. 2. C-terminal truncation modulates critical concentration. The
dependence of ﬁbrillization plateau on s concentration was determined
in the presence of 100 lM thiazin red after 24 h incubation at 20 C by
quantitative electron microscopy. Each data point represents the
mean ± S.D. of triplicate determinations (hs40, d; hs40D422, s;
hs40D392, j) whereas the solid lines represent best ﬁt of the data
points to a linear regression. The critical monomer concentration,
which was estimated from the abscissa intercept of each regression line
(summarized in Table 1), was modulated by C-terminal truncation.
Table 1
Kinetic constants for s aggregation reactions
Protein Kcrit (nM) Lag time (h)
a kapp (h
1)a
Hs40 207 ± 9 1.84 ± 0.12 0.25 ± 0.03
Hs40D422 156 ± 13 1.16 ± 0.07 0.54 ± 0.03
Hs40D392 60 ± 29 1.13 ± 0.12 0.45 ± 0.05
aDetermined at constant supersaturation (A  Kcrit = 600 nM).Kn, or increase nucleus cluster size n will increase the rate of
ﬁlament nucleation at a given bulk s concentration. To assess
the inﬂuence of C-terminal truncation on nucleation rate inde-
pendent of supersaturation eﬀects, the ﬁbrillization time
courses of hs40, hs40D392 and hs40D422 were followed by
TEM over a period of 24 h (room temperature, no agitation)
at constant supersaturation (i.e., bulk s concentrations were
varied on the basis of measured Kcrit summarized in Table 1
so that A  Kcrit for all reactions was 600 nM). All resultant
reaction progress curves were sigmoidal with clear lag, expo-
nential growth, and plateau phases (Fig. 3). Despite being
incubated at lower bulk s concentrations, and equivalent levels
of supersaturation, both C-terminal truncations aggregated
with signiﬁcantly shorter lag times than did wild-type hs40
(Fig. 3; Table 1). Because lag times vary inversely with nucle-
ation rate, these data indicate that truncation of as little as 20
residues from the C-terminus of s can accelerate nucleation
rate. As a result, the pseudo-ﬁrst order rate constant for aggre-
gation, kapp, approximately doubled with C-terminal trunca-
tion when supersaturation was held constant (Table 1).Fig. 3. C-terminal truncation speeds the rate of s aggregation. The
time course (20 C) of hs 40 (0.81 lM; d), hs40D422 (0.76 lM; s), and
hs40D392 (0.67 lM; j) ﬁbrillization in the presence of 100 lM thiazin
red inducer was determined by TEM. Protein concentrations were
varied so that the driving force for nucleation (A  Kcrit) of all samples
was held constant at 0.6 lM. Each data point represents the average of
duplicate determinations of total ﬁlament length/ﬁeld (Cf, expressed as
a percentage of the value at plateau) whereas each sigmoid curve
represents the best ﬁt of the data points to a three-parameter Gompertz
function (Eq. (1)). Even when adjusted for diﬀerences in critical
concentration, C-terminal truncation mutants aggregated with shorter
lag times than full-length hs40, suggesting that C-terminal truncation
increases nucleation eﬃciency.
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modulating both pre- and post-nuclear equilibria, leading to
lower critical concentrations and faster rates of nucleation.
Both of these eﬀects contribute to the increased velocity of
aggregation observed macroscopically and underlie the amy-
loid-promoting eﬀects of truncation.4. Discussion
s Filament formation in tauophathic neurodegenerative dis-
eases such as AD appears to follow a primary nucleation
mechanism: the phase transition proceeds from non-ﬁbrillar
s without the participation of preexisting ﬁlaments formed as
a result of normal cell function. Early morphological analyses
of neuroﬁbrillary lesions completed using TEM found s ﬁla-
ments accumulating within the neuronal cytoplasm [32]. These
appeared to enter and exit the plane of section owing to the
curvature of the cell and therefore gave the appearance of ﬁl-
ament ends being free in the cytoplasm. This morphological
pattern is superﬁcially consistent with primary nucleation
being homogeneous, where s molecules spontaneously self-
associate to nucleate and extend ﬁlaments without the contri-
bution of foreign particles. The results found herein suggest
that under these aggregation conditions, C-terminal truncation
would have a signiﬁcant eﬀect on both the nucleation and
extension phases of ﬁbrillization. Nucleation would be greatly
accelerated, owing to the decrease in critical concentration,
which increases ﬁbrillization driving force, and to the direct
and positive eﬀect of truncation on nucleation eﬃciency. The
decrease in critical concentration also would better support
ﬁbrillization at the low free s concentrations that likely exist
at early stages of the ﬁbrillization reaction. Filaments formed
from preferential nucleation and extension of C-terminally
truncated s may facilitate secondary nucleation of full-length
monomeric s and therefore mediate the recently postulated
‘‘seeding’’ eﬀect of truncated s in vitro [6,15].
More recent morphological analyses of neuroﬁbrillary tan-
gles employed serial sections to follow the course of ﬁlaments
through the neuronal cytoplasm [33]. These studies found that
many ﬁlament ends are in fact not free in solution, but inti-
mately associated with intracellular bodies [33]. Moreover, at
least a portion of s molecules begin the transition from na-
tively unfolded to extended b-sheet conformation in associa-
tion with intracellular membranes [34]. Together these
observations suggest that heterogeneous nucleation and
growth of s ﬁlaments may be the dominant pathway in vivo,
where foreign bodies supply a surface which selectively binds
s and facilitates the adoption of extended b-sheet structure
and ﬁlament nucleation at levels of supersaturation well below
those needed to support homogeneous nucleation [18]. Rates
of heterogeneous nucleation depend almost entirely on inducer
concentration as supersaturation rises [22]. Under these condi-
tions, the nucleation-promoting eﬀects of C-terminal trunca-
tion may be substantially lower than under homogeneous
nucleation conditions. For example, certain s pseudophosph-
orylation mutants have lower Kcrit than wild-type s and there-
fore greater supersaturation at a given bulk s concentration,
but this does not lead to faster nucleation rates under hetero-
geneous nucleation conditions [35]. Similarly, the primary
amyloidogenic mechanism for C-terminal truncations that
lower Kcrit under heterogeneous nucleation conditions wouldbe to support ﬁlament formation at low free s concentrations
(i.e., when s is mostly bound by microtubules).
Finally, recent studies suggest that C-terminal truncation,
while occurring early in the course of disease, actually occurs
after ﬁlament nucleation [36]. Under these conditions, trunca-
tion would have no role in modulating nucleation, but could
facilitate the accumulation of ﬁlaments at early stages of dis-
ease when ambient free s concentrations are low. Thus, even
when occurring late in the aggregation pathway, C-terminal
truncation is predicted to have signiﬁcant positive eﬀects on
aggregation eﬃciency.
In each of the scenarios summarized above, C-terminal trun-
cation does not necessarily trigger the conformational changes
needed for aggregation to occur, but rather enhances the reac-
tion by lowering critical concentration and making nucleation
more eﬃcient. The eﬀect is somewhat surprising because the s
molecule C-terminal to the microtubule-binding region is
acidic, and so virtually any truncation leads to a modest in-
crease in both isoelectric point and net charge at physiological
pH. On the basis of electrostatic repulsion, both of these
changes should raise solubility and decrease rates of aggrega-
tion [37]. In the case of s protein, however, it appears that
other factors (such as speciﬁc charge–charge interactions, sur-
face exposure of hydrophobic residues, or stabilization of ex-
tended conformation; [38–41]) rather than isoelectric point
predominate under the near-physiological assembly conditions
employed here. For example, the aggregation promoting eﬀect
of s pseudophosphorylation mutagenesis is site speciﬁc, even
though isoelectric point decreases equally in all mutations
[35,42]. Moreover, the depression of Kcrit observed in pseud-
ophosphorylation mutant hs40T212E relative to wild-type
hs40 results from diminished rates of disaggregation rather
than increased rates of aggregation [42]. These results parallel
the eﬀect of surface salt-bridge formation on globular protein
folding stability, which acts to stabilize the folded state by
decreasing rates of unfolding without increasing rates of fold-
ing [43,44]. The decreased Kcrit associated with C-terminal
truncation in the face of increased net charge suggests that it
also facilitates speciﬁc contacts irrespective of global charge
considerations.
In summary, C-terminal truncation of as few as 20 residues
from full-length four-repeat s can have signiﬁcant eﬀects on
aggregation kinetics by acting at the levels of ﬁlament nucle-
ation and extension. The speciﬁc eﬀects on neuritic lesion for-
mation will depend on the timing of truncation relative to
ﬁlament nucleation in disease. However, the extension promot-
ing activity is especially pronounced and will act to support s
ﬁbrillization at low free s concentrations under all pathophys-
iologically relevant scenarios.Acknowledgments: We thank Dr. Aida Abraha (Chicago St. Univer-
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